Hypertension patients on the rise in BD

block
Tareen Rahman :
Every day the number of hypertension (HTN) patients are increasing in Bangladesh.Whereas, in earlier days, the problem used to begin among people of 30-35 years of age, now even youngsters of 17 to 18 years are developing this disease.
In Bangladesh , approximately 20 pc of adult and 40-65 pc of elderly people suffer from HTN. High incidence of metabolic syndrome, and lifestyle-related factors like obesity, high salt intake, more inclination towards fatty and fast foods, stress in every day life and less physical activity are the main causes behind this.
The association of angiotensin-converting enzyme (ACE) gene polymorphism and low birth weight with blood pressure has been studied inadequately. Studies have found relationship between mass arsenic poisoning and HTN.
Hypovitaminosis D presumably plays role in the aetiopathogenesis of HTN in Bangladeshi population. South Asians appear to respond to antihypertensive therapy in a similar manner to the Whites.
The latest National Institute for Health and Clinical Excellence guideline advocates a calcium-channel blocker as step 1 antihypertensive treatment to people aged > 55 years and an ACE inhibitor or  
a low-cost angiotensin-II receptor blocker for the younger people.
Calcium-channel blockers and beta-blockers have been found to be the most commonly prescribed antihypertensive drugs in Bangladesh. Non-adherence to the standard guidelines and irrational drug prescribing are likely to be the cause behind the disease being so much prevalent among Bangladeshis. On the other hand, non-adherence to antihypertensive treatment is quite high.
block